GOCO has 36-month beta value of 1.63. Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for GOCO is 8.49M, and currently, short sellers hold a 1.42% ratio of that float. The average trading volume of GOCO on February 28, 2025 was 55.07K shares.
GOCO) stock’s latest price update
GoHealth Inc (NASDAQ: GOCO) has seen a decline in its stock price by -14.45 in relation to its previous close of 18.41. However, the company has experienced a -13.75% decline in its stock price over the last five trading sessions. seekingalpha.com reported 2025-02-27 that GoHealth, Inc. (NASDAQ:GOCO ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants John Shave – Vice President, Investor Relation Vijay Kotte – Chief Executive Officer Brendan Shanahan – Chief Financial Officer Conference Call Participants Ben Hendrix – RBC Capital Markets Pat McCann – Noble Capital Markets Robert McGuire – Granite Research Jim Sidoti – Sidoti & Company Dave Storms – Stonegate Inc. Operator Good morning, and welcome to the GoHealth Fourth Quarter and Full Year 2024 Earnings Conference Call. My name is Olivia, and I will be your operator for today’s call.
GOCO’s Market Performance
GoHealth Inc (GOCO) has seen a -13.75% fall in stock performance for the week, with a -5.86% decline in the past month and a 32.35% surge in the past quarter. The volatility ratio for the week is 13.87%, and the volatility levels for the past 30 days are at 8.67% for GOCO. The simple moving average for the last 20 days is -8.33% for GOCO stock, with a simple moving average of 35.89% for the last 200 days.
Analysts’ Opinion of GOCO
Many brokerage firms have already submitted their reports for GOCO stocks, with Credit Suisse repeating the rating for GOCO by listing it as a “Underperform.” The predicted price for GOCO in the upcoming period, according to Credit Suisse is $1.50 based on the research report published on April 01, 2022 of the previous year 2022.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see GOCO reach a price target of $2, previously predicting the price at $10. The rating they have provided for GOCO stocks is “Sector Perform” according to the report published on March 03rd, 2022.
GOCO Trading at 3.07% from the 50-Day Moving Average
After a stumble in the market that brought GOCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.25% of loss for the given period.
Volatility was left at 8.67%, however, over the last 30 days, the volatility rate increased by 13.87%, as shares sank -1.62% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +40.75% upper at present.
During the last 5 trading sessions, GOCO fell by -13.75%, which changed the moving average for the period of 200-days by +67.20% in comparison to the 20-day moving average, which settled at $17.18. In addition, GoHealth Inc saw 17.63% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for GOCO
Current profitability levels for the company are sitting at:
- -0.01 for the present operating margin
- 0.8 for the gross margin
The net margin for GoHealth Inc stands at 0.05. The total capital return value is set at -0.01. Equity return is now at value -13.48, with -2.14 for asset returns.
Based on GoHealth Inc (GOCO), the company’s capital structure generated 0.25 points at debt to capital in total, while cash flow to debt ratio is standing at -0.57. The debt to equity ratio resting at 0.33. The interest coverage ratio of the stock is -0.1.
Currently, EBITDA for the company is -7.05 million with net debt to EBITDA at 0.26. When we switch over and look at the enterprise to sales, we see a ratio of 0.25. The receivables turnover for the company is 0.76for trailing twelve months and the total asset turnover is 0.54.
Conclusion
To put it simply, GoHealth Inc (GOCO) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
